We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 6 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 13. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2026. 04. 20. | Goldman Sachs | — | Downgrade | Neutral → Sell | — | Goldman Sachs: Neutral → Sell |
| 2026. 03. 13. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 01. 06. | Raymond James | — | Downgrade | Outperform → Market Perform | — | Raymond James: Outperform → Market Perform |
| 2025. 10. 25. | Raymond James | — | Maintain | Outperform → Outperform | — | Raymond James: Outperform |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.